Epsilon Healthcare Limited
HDRPF
$0.0014
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -3.61% | -2.68% | 56.57% | 61.45% | -8.25% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -3.61% | -2.68% | 56.57% | 61.45% | -8.25% |
| Cost of Revenue | -61.27% | -60.89% | 168.40% | 176.79% | 0.46% |
| Gross Profit | 160.25% | 162.67% | -120.97% | -121.60% | -26.40% |
| SG&A Expenses | -46.10% | -45.59% | -16.47% | -13.87% | -54.86% |
| Depreciation & Amortization | 53.66% | 55.12% | 149.94% | 157.79% | -13.77% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -38.73% | -38.15% | 48.79% | 53.42% | -38.59% |
| Operating Income | 77.95% | 77.74% | -43.35% | -47.81% | 55.15% |
| Income Before Tax | 91.70% | 91.62% | 14.81% | 12.16% | -63.53% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 91.70% | 91.62% | 7.46% | 4.58% | -80.26% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 91.70% | 91.62% | 7.46% | 4.58% | -80.26% |
| EBIT | 77.95% | 77.74% | -43.35% | -47.81% | 55.15% |
| EBITDA | 117.23% | 117.38% | -21.46% | -25.23% | 60.77% |
| EPS Basic | 93.70% | 93.75% | -2.11% | -5.21% | -51.19% |
| Normalized Basic EPS | 75.00% | 76.19% | -105.56% | -108.11% | 64.29% |
| EPS Diluted | 93.70% | 93.75% | -2.11% | -5.21% | -51.19% |
| Normalized Diluted EPS | 75.00% | 76.19% | -105.56% | -108.11% | 64.29% |
| Average Basic Shares Outstanding | 30.93% | 30.93% | -9.30% | -9.30% | 19.50% |
| Average Diluted Shares Outstanding | 30.93% | 30.93% | -9.30% | -9.30% | 19.50% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |